0001209191-15-074429.txt : 20151006
0001209191-15-074429.hdr.sgml : 20151006
20151006185908
ACCESSION NUMBER: 0001209191-15-074429
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151006
FILED AS OF DATE: 20151006
DATE AS OF CHANGE: 20151006
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001557746
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460571712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SUITE 400, 101 LINDENWOOD DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-321-5554
MAIL ADDRESS:
STREET 1: SUITE 400, 101 LINDENWOOD DRIVE
CITY: MALVERN
STATE: PA
ZIP: 19355
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POWELL MICHAEL
CENTRAL INDEX KEY: 0001202793
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 151147496
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AKKARAJU SRINIVAS
CENTRAL INDEX KEY: 0001253170
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 151147497
MAIL ADDRESS:
STREET 1: 18 DESBROSSES STREET
CITY: NEW YORK
STATE: NY
ZIP: 10013
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HEALY JAMES
CENTRAL INDEX KEY: 0001245624
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 151147498
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sofinnova Management VIII, L.L.C.
CENTRAL INDEX KEY: 0001559565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 151147499
BUSINESS ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-681-8420
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sofinnova Venture Partners VIII, L.P.
CENTRAL INDEX KEY: 0001524064
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 151147500
BUSINESS ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-681-8420
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2015-10-06
0
0001557746
Aclaris Therapeutics, Inc.
ACRS
0001524064
Sofinnova Venture Partners VIII, L.P.
SOFINNOVA VENTURES, 3000
SAND HILL ROAD, 4-250
MENLO PARK
CA
94025
0
0
1
0
0001559565
Sofinnova Management VIII, L.L.C.
SOFINNOVA VENTURES, 3000
SAND HILL ROAD, 4-250
MENLO PARK
CA
94025
0
0
1
0
0001245624
HEALY JAMES
SOFINNOVA VENTURES, 3000
SAND HILL ROAD, 4-250
MENLO PARK
CA
94025
0
0
1
0
0001253170
AKKARAJU SRINIVAS
SOFINNOVA VENTURES, 3000
SAND HILL ROAD, 4-250
MENLO PARK
CA
94025
0
0
1
0
0001202793
POWELL MICHAEL
SOFINNOVA VENTURES, 3000
SAND HILL ROAD, 4-250
MENLO PARK
CA
94025
0
0
1
0
Series A Preferred Stock
Common Stock
579710
D
Series B Preferred Stock
Common Stock
702678
D
Series C Preferred Stock
Common Stock
598002
D
Each share of the Series A Preferred Stock is convertible, at any time, at the holder's election, into 0.289855 shares of the Issuer's common stock. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series A Preferred Stock will automatically convert into 0.289855 shares of the Issuer's common stock. The Series A Preferred Stock has no expiration date.
The shares are held of record by Sofinnova Venture Partners VIII, L.P. ("SVP VIII"). Sofinnova Management VIII, L.L.C. ("SM VIII") is the general partner of SVP VIII. The individual managing members of SVP VIII are Michael Powell, James Healy, Srinivas Akkaraju and Anand Mehra, and they may be deemed to share voting and dispositive power over the shares held by SVP VIII. Such persons and entities disclaim beneficial ownership over the shares held by SVP VIII except to the extent of any pecuniary interest therein.
Each share of the Series B Preferred Stock is convertible, at any time, at the holder's election, into 0.289855 shares of the Issuer's common stock. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series B Preferred Stock will automatically convert into 0.289855 shares of the Issuer's common stock. The Series B Preferred Stock has no expiration date.
Each share of the Series C Preferred Stock is convertible, at any time, at the holder's election, into 0.289855 shares of the Issuer's common stock. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series C Preferred Stock will automatically convert into 0.289855 shares of the Issuer's common stock. The Series C Preferred Stock has no expiration date.
/s/ Nathalie Auber, Attorney-in-Fact for Sofinnova Venture Partners VIII, L.P.
2015-10-06
/s/ Nathalie Auber, Attorney-in-Fact for Sofinnova Management VIII, L.L.C.
2015-10-06
/s/ Nathalie Auber, Attorney-in-Fact for James Healy
2015-10-06
/s/ Nathalie Auber, Attorney-in-Fact for Srinivas Akkaraju
2015-10-06
/s/ Nathalie Auber, Attorney-in-Fact for Michael Powell
2015-10-06